专利检索 ap:("Regents of the University of Minnesota" OR "GT Biopharma, Inc.") AND inv:"MILLER, Jeffrey, S." 第 1 页

1.

发明公开
IMMUNOTHERAPY COMPOUNDS AND METHODS 审中-公开

公开(公告)号：EP4031565A1

公开(公告)日：2022-07-27

申请号：EP20864423.7

申请日：2020-09-15

申请人： Regents of the University of Minnesota , GT Biopharma, Inc.

发明人： VALLERA, Daniel, A. , MILLER, Jeffrey, S. , FELICES, Martin , SCHROEDER, Martin

IPC分类号： C07K14/54 , C07K16/28 , C07K16/30

2.

发明公开
NK ENGAGER COMPOUNDS THAT BIND VIRAL ANTIGENS AND METHODS OF USE 审中-公开

公开(公告)号：EP4041757A1

公开(公告)日：2022-08-17

申请号：EP20870067.4

申请日：2020-09-25

申请人： Regents of the University of Minnesota

发明人： MILLER, Jeffrey, S. , FELICES, Martin , LENVIK, Todd , VALLERA, Daniel, A.

IPC分类号： C07K14/54 , C07K16/10 , C07K16/28

3.

发明公开
NK ENGAGER MOLECULES AND METHODS OF USE THEREOF 审中-公开

公开(公告)号：EP3867278A1

公开(公告)日：2021-08-25

申请号：EP19873982.3

申请日：2019-10-17

申请人： Regents of the University of Minnesota

发明人： MILLER, Jeffrey, S. , FELICES, Martin , VALLERA, Daniel, A. , LENVIK, Todd, R.

IPC分类号： C07K16/28 , C07K16/30 , C07K19/00 , C07K14/54 , C07K14/42 , C12N5/0783

4.

发明公开
THERAPEUTIC COMPOUNDS AND METHODS 审中-公开

公开(公告)号：EP3359168A1

公开(公告)日：2018-08-15

申请号：EP16854310.6

申请日：2016-10-06

申请人： Regents of the University of Minnesota

发明人： VALLERA, Daniel, Attilio , MILLER, Jeffrey, S.

IPC分类号： A61K35/17 , C07K16/28 , C07K16/46 , C12N5/00 , C12N5/0783

CPC分类号： C07K14/55 , A61K38/00 , C07K14/5443 , C07K16/1045 , C07K16/244 , C07K16/2803 , C07K16/2809 , C07K16/283 , C07K16/30 , C07K2317/22 , C07K2317/54 , C07K2317/55 , C07K2317/622 , C07K2319/33 , C12N5/0646

摘要： This disclosure describes engineered compounds that engage NK cells and methods of using the compounds. Generally, the compound includes an NK engaging domain, a targeting domain that selectively binds to a target cell, and an NK activating domain operably linking the NK engaging domain and the targeting domain.